Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals
G
George W. Sledge
T
Takayuki Yoshino
(National Cancer Center Hospital East, Kashiwa, Japan)
J
Joanne Xiu
A
Anthony Helmstetter
J
Jennifer R. Ribeiro
S
Sergey Klimov
B
Brady Gilg
J
JJ Gao
J
Jeff Elton
M
Matthew J. Oberley
M
Milan Radovich
J
Jim Abraham
D
David Spetzler
Article Details
Journal
Nature Communications
Volume / Issue
Vol. 16, Issue 1
Published
March 18, 2025
ISSN
2041-1723
Publisher
Nature Portfolio
Authors (13)
G
George W. Sledge
T
Takayuki Yoshino
National Cancer Center Hospital East, Kashiwa, Japan
J
Joanne Xiu
A
Anthony Helmstetter
J
Jennifer R. Ribeiro
S
Sergey Klimov
B
Brady Gilg
J
JJ Gao
J
Jeff Elton
M
Matthew J. Oberley
M
Milan Radovich
J
Jim Abraham
D
David Spetzler
Related Articles from this Journal
Synthesis of adaptive 15N-nitrosyl-Co7 nanocluster for electrocatalytic C–H functionalization
Chao Wu, Xu Zhang et al.
Aug 2026
10.1038/s41467-026-76516-1
Pan-Ebolavirus nanoparticle vaccine provides protection in rodents from lethal infection by Zaire and Sudan viruses
Connor Weidle, Natalie Brunette et al.
Aug 2026
10.1038/s41467-026-76114-1
Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk
Ludmila Prokunina-Olsson, Oscar Florez-Vargas et al.
Aug 2026
10.1038/s41467-026-76157-4
Genome-wide annotation of human multi-nucleotide variants reveals widespread functional differences from single nucleotide variants
Weiwei Jin, Wen Cao et al.
Aug 2026
10.1038/s41467-026-76470-y
Allele-specific chromatin architecture shapes imprinted domains and coordinates a distal enhancer and antisense transcription at the mouse Mest-Copg2 domain
Bongmin Bae, Katherine Gu et al.
Aug 2026
10.1038/s41467-026-76506-3